Dentsply Sirona Inc. (XRAY) Stock Price & Analysis
Dentsply Sirona Inc. (XRAY) rose 2.05% to USD 10.47 as of June 10, 2026 at 00:38 UTC, according to Nexqual real-time market data.
XRAY last closed at USD 10.26; the session ranged USD 10.22–10.67 on volume of 5,478,503 shares. Market capitalization is $2.10B, with a 52-week range of USD 9.41–17.09 (NMS). Source: Nexqual, June 10, 2026 at 00:38 UTC.
Key Statistics (as of June 10, 2026 at 00:38 UTC)
| Price | USD 10.47 |
|---|---|
| Change | ▲ 2.05% (up) |
| Previous Close | USD 10.26 |
| Open | USD 10.38 |
| Day Range | USD 10.22 – 10.67 |
| 52-Week Range | USD 9.41 – 17.09 |
| Volume | 5,478,503 shares |
| Market Cap | $2.10B |
| Exchange | NMS |
Technical Analysis (XRAY)
Nexqual's technical model rates XRAY "SELL" based on 2 bullish and 4 bearish signals across 124 daily candles, as of June 10, 2026 at 00:38 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 48.2 (neutral) |
| vs SMA50 | Below (USD 11.09) |
| MACD | -0.28 (negative) |
Analyst Ratings (XRAY)
Wall Street analysts rate XRAY "Hold" based on 15 analysts, with a mean price target of USD 13.4 (range USD 9–17), per Nexqual as of June 10, 2026 at 00:38 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 15 |
| Mean Target | USD 13.4 |
| High Target | USD 17 |
| Low Target | USD 9 |
| Buy / Hold / Sell | 4 / 11 / 2 |
Earnings (XRAY)
| Next Earnings Date | 2026-05-05 |
|---|---|
| EPS Estimate | USD 0.35 |
| Revenue Estimate | $888.14M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.27 vs est 0.27 ▼ miss |
| 2025-12-31 | USD 0.27 vs est 0.29 ▼ miss |
| 2025-09-30 | USD 0.37 vs est 0.45 ▼ miss |
| 2025-06-30 | USD 0.52 vs est 0.5 ▲ beat |
Source: Nexqual, June 10, 2026 at 00:38 UTC.
Financials & Fundamentals (XRAY)
| Total Revenue | $3.68B |
|---|---|
| Revenue Growth (YoY) | +0.10% |
| Gross Margin | +48.93% |
| Operating Margin | +3.41% |
| Profit Margin | -17.06% |
| ROE | -37.67% |
| Debt / Equity | 177.79 |
| Current Ratio | 1.53 |
| Total Cash | $190.00M |
| Total Debt | $2.34B |
| Free Cash Flow | $129.63M |
Source: Nexqual, June 10, 2026 at 00:38 UTC.
Financial Health Score (XRAY)
Nexqual rates Dentsply Sirona Inc.'s overall financial health "Weak" across five dimensions, as of June 10, 2026 at 00:38 UTC.
| Growth | Weak — Revenue -3% YoY (annual), declining |
|---|---|
| Profitability | Solid — Gross margin 49%, operating 3% |
| Balance Sheet | Weak — $190M cash vs $2.34B debt |
| Cash Flow | Mixed — FCF $130M, slim 3.5% margin |
| Efficiency | Critical — ROE -38%, ROA 2.3% |
Ownership (XRAY)
| Insider Ownership | +0.58% |
|---|---|
| Institutional Ownership | +110.13% |
| Shares Outstanding | 200.33M |
| Float | 199.42M |
| Short % of Float | +12.18% |
Source: Nexqual, June 10, 2026 at 00:38 UTC.
Leadership (XRAY)
Dentsply Sirona Inc. is led by Daniel T. Scavilla (age 60), President, CEO, Interim Principal Financial Officer & Director, per Nexqual as of June 10, 2026 at 00:38 UTC.
| President, CEO, Interim Principal Financial Officer & Director | Daniel T. Scavilla (age 60) |
|---|---|
| Interim Chief Financial Officer | Michael C. Pomeroy (age 67) |
| Vice President & Chief Accounting Officer | Kevin J. Czerney (age 41) |
| Senior VP & Chief Technology Officer | Kevin Boyle |
Major Backers & Investors (XRAY)
Notable institutional backers of Dentsply Sirona Inc. include First Eagle Investment Management, LLC, Fuller & Thaler Asset Management Inc., Southpoint Capital Advisors Lp, according to Nexqual as of June 10, 2026 at 00:38 UTC.
Active Investors
| Investor | Stake |
|---|---|
| First Eagle Investment Management, LLC | 12.76% |
| Fuller & Thaler Asset Management Inc. | 6.39% |
| Southpoint Capital Advisors Lp | 4.99% |
| UNDISCOVERED MANAGERS Fd.S-Undiscovered Managers Behavioral Value Fd. | 4.66% |
| Cooke & Bieler LP | 3.89% |
| Lazard Asset Management LLC | 3.35% |
| Ariel Investments, LLC | 3.19% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 18.94% |
| BlackRock | 12.97% |
| State Street | 3.62% |
Source: Nexqual, June 10, 2026 at 00:38 UTC.
From Dentsply Sirona Inc.'s Latest SEC 10-K Filing (filed 2026-02-26)
Key Strengths & Strategy (as disclosed to the SEC)
- As of December 31, 2025, the Company and its subsidiaries employed approximately 14,000 employees globally, including approximately 3,000 in the United States.
- Dentsply Sirona believes that its principal strengths include its well-established brand names, its end-to-end dental portfolio, its reputation for high quality and innovative products, its leadership in product development and manufacturing, its global sales force, the breadth of its distribution network, its commitment to customer satisfaction and the support of the Company's products by dental and medical professionals.
- Dentsply Sirona also owns and maintains more than 5,000 patents throughout the world and has also licensed a number of patents owned by others.
Partnerships
- We continue our partnership with Prosci, a global leader in change‑management methodology and research.
- In 2025, we partnered with Korn Ferry to offer the Professional Selling Skills® ("PSS") suite of courses to standardize global sales training and drive growth.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HSIC | Henry Schein, Inc. | USD 80.03 | ▲ 3.33% |
| COO | The Cooper Companies, Inc. | USD 68.62 | ▲ 1.9% |
| CHRW | C.H. Robinson Worldwide, Inc. | USD 191.65 | ▲ 4.11% |
| EXPD | Expeditors International of Was | USD 166.34 | ▲ 3.68% |
| TFX | Teleflex Incorporated | USD 135.75 | ▲ 4.55% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:38 UTC. This page is informational and not investment advice.